The iPad Age is upon us, as Bloomberg reports that Otsuka Pharma is buying 1,300 of the devices for its sales reps in Japan. If it goes well, the company, which co-promotes Abilify with Bristol-Myers Squibb in Europe and the US, might arm its sales forces with the iPad globally.
Company News: Otsuka Pharma
The iPad Age is upon us, as Bloomberg reports that Otsuka Pharma is buying 1,300 of the devices for its sales reps in Japan.
